Cargando…
Fibroblast growth factor 21 resistance is associated with body shape in patients with type 2 diabetes complicating hypertension
OBJECTIVES: Obesity, especially abdominal obesity, increases the prevalence of metabolic and cardiovascular disease (CVD). Fibroblast growth factor 21 (FGF21) has been identified as a critical regulator playing a therapeutic role in diabetes and its complications. This study aims to evaluate the rel...
Autores principales: | Gan, Jing, Duan, Zikun, Tang, Lu, Liu, Zhen, Tian, Huiying, Wu, Maolan, Bi, Yanxue, Pan, Xingchao, Wang, Wenjun, Gao, Xiaotang, Wang, Ningrui, Lin, Zhuofeng, Yang, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10325616/ https://www.ncbi.nlm.nih.gov/pubmed/37424900 http://dx.doi.org/10.3389/fcvm.2023.1168047 |
Ejemplares similares
-
Extracellular status of thrombospondin-2 in type 2 diabetes mellitus and utility as a biomarker in the determination of early diabetic kidney disease
por: Lin, Zhenzhen, et al.
Publicado: (2023) -
Fibroblast Growth Factor 21 Protects Against Atrial Remodeling via Reducing Oxidative Stress
por: Chen, Miao, et al.
Publicado: (2021) -
Mechanism of fibroblast growth factor 21 in cardiac remodeling
por: Zhao, Zeyu, et al.
Publicado: (2023) -
Emerging roles of fibroblast growth factor 21 in critical disease
por: Yan, Fang, et al.
Publicado: (2022) -
Fibroblast Growth Factor 21 Protects against Atherosclerosis via Fine-Tuning the Multiorgan Crosstalk
por: Jin, Leigang, et al.
Publicado: (2016)